← Back to All Stocks

Coherus Oncology, Inc. (CHRS) Analysis

Generated on: 2025-07-31 12:37:35 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.

Analysis Values

Current Price
$1.07
Predicted Price
$1.05
Expected Return
-1.13%
Confidence Score
0.81
RSI (14)
59.48
MACD
0.06
Volume
1,454,400
Float Shares
110,892,497
Reddit Posts
1
News Items
1
SEC Filings
0
Data Points
250

CHRS

Coherus Oncology, Inc.
-1.13%
Price: $1.07
Confidence: 0.81
Reddit
News
Last updated: 2025-07-31 12:37:34

Technical Analysis

RSI: 59.48
MACD: 0.06
Technical Analysis Graph

Risk Analysis

Volatility
98.56%
Max Drawdown
-57.84%
Beta
1.0
Risk Score
82.6

Social Sentiment

76.2
Social Sentiment Score (0-100)

Recent News

News thumbnail
Strength Seen in Krystal Biotech (KRYS): Can Its 4.2% Jump Turn into More Strength?
Zacks - 2025-06-25 13:55
Krystal Biotech (KRYS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Reddit Discussions

$CHRS Earnings Preview
r/pennystocks - 2025-07-26 01:03 - Score: 43 - Comments: 45
 **Bonus for y’all**: Here’s a gift for anyone who wants to grab it. I’ve done the homework on this one and I see serious potential. If CHRS catches fire, we could be looking at a run to **$5–$7** short term. Take it or leave it . I’m in. **$CHRS Earnings Preview – High Risk, High Reward Setup Incoming**   **What to Know Before the Call:**  **Transformation Complete** CHRS is now *Coherus Oncology*. fully focused on immuno-oncology after selling its biosimilar unit *UDENYCA* for up to **$55...

Recent SEC Filings

No recent SEC filings found.